Samsung Bioepis Co., Ltd. v. Regeneron Pharmaceuticals, Inc. > Summary
Court Case Number IPR2025-00176
Filing Date Nov 20, 2024
Institution Decision Date Jun 2, 2025
Decision Date Jun 2, 2025
Court Patent Trial and Appeal Board
Status Institution Denied
Administrative JudgesMichael Valek, Susan L. C. Mitchell, Jamie T. Wisz
Judge Writing the Final DecisionMichael Valek
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 14, 15, 16, 17, 19, 20, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 39, 40, 41, 42, 44, 45, 47, 48, 49, 50, 51, 52, 53, 54, 55
Petitioner
Patent Owner
Petitioner Attorneys
8samsung bioepis
Attorney Name: Edward Chaum
University of Memphis
samsung bioepis
Attorney Name: Alpaslan Yaman
Rubin/Anders
samsung bioepis
Attorney Name: Michael A. Butler
University College Dublin
samsung bioepis
Attorney Name: Richard Manning
Intensity, LLC
samsung bioepis
Attorney Name: Raymond N. Nimrod
Quinn Emanuel Urquhart & Sullivan
samsung bioepis
Attorney Name: Landon A. Smith
Quinn Emanuel Urquhart & Sullivan
samsung bioepis
Attorney Name: Zachariah Summers
Quinn Emanuel Urquhart & Sullivan
samsung bioepis
Attorney Name: Elliot Choi
Quinn Emanuel Urquhart & Sullivan
Patent Owner Attorneys
5Regeneron Pharmaceuticals
Attorney Name: David I. Berl
Williams & Connolly
Regeneron Pharmaceuticals
Attorney Name: Andrew V. Trask
Williams & Connolly
Regeneron Pharmaceuticals
Attorney Name: Arthur J. Argall III
Williams & Connolly
Regeneron Pharmaceuticals
Attorney Name: Priyata Y. Patel
Paul Weiss Rifkind Wharton & Garrison
Regeneron Pharmaceuticals
Attorney Name: Elizabeth S. Weiswasser
Paul Weiss Rifkind Wharton & Garrison
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 11084865 | VEGF antagonist formulations suitable for intravitreal administration | Aug 10, 2021 |
